Can Sitagliptin enhance the effects of structured exercise programs on improving glycemic control and overall metabolic health in diabetics?
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Sitagliptin, a DPP-4 inhibitor, may enhance the effects of structured exercise in diabetics by improving insulin secretion and glycemic control, potentially boosting the benefits on metabolic health.